GB202000840D0 - Compositions and methods - Google Patents

Compositions and methods

Info

Publication number
GB202000840D0
GB202000840D0 GBGB2000840.5A GB202000840A GB202000840D0 GB 202000840 D0 GB202000840 D0 GB 202000840D0 GB 202000840 A GB202000840 A GB 202000840A GB 202000840 D0 GB202000840 D0 GB 202000840D0
Authority
GB
United Kingdom
Prior art keywords
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2000840.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CELL GUIDANCE SYSTEMS Ltd
Cambridge Enterprise Ltd
Original Assignee
CELL GUIDANCE SYSTEMS Ltd
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CELL GUIDANCE SYSTEMS Ltd, Cambridge Enterprise Ltd filed Critical CELL GUIDANCE SYSTEMS Ltd
Priority to GBGB2000840.5A priority Critical patent/GB202000840D0/en
Publication of GB202000840D0 publication Critical patent/GB202000840D0/en
Priority to PCT/GB2021/050112 priority patent/WO2021148779A1/en
Priority to EP21702301.9A priority patent/EP4093425A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
GBGB2000840.5A 2020-01-21 2020-01-21 Compositions and methods Ceased GB202000840D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2000840.5A GB202000840D0 (en) 2020-01-21 2020-01-21 Compositions and methods
PCT/GB2021/050112 WO2021148779A1 (en) 2020-01-21 2021-01-18 Polyhedrin delivery system releasing growth factors
EP21702301.9A EP4093425A1 (en) 2020-01-21 2021-01-18 Polyhedrin delivery system releasing growth factors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2000840.5A GB202000840D0 (en) 2020-01-21 2020-01-21 Compositions and methods

Publications (1)

Publication Number Publication Date
GB202000840D0 true GB202000840D0 (en) 2020-03-04

Family

ID=69636764

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2000840.5A Ceased GB202000840D0 (en) 2020-01-21 2020-01-21 Compositions and methods

Country Status (3)

Country Link
EP (1) EP4093425A1 (en)
GB (1) GB202000840D0 (en)
WO (1) WO2021148779A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911212B2 (en) 1998-02-27 2005-06-28 Musculoskeletal Transplant Foundation Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects
JP4230222B2 (en) 2000-10-30 2009-02-25 株式会社プロテインクリスタル Protein complex and method for producing the same
DE602004026157D1 (en) 2003-01-10 2010-05-06 Protein Crystal Co Ltd PROTEIN COMPLEX, METHOD FOR THE PRODUCTION AND USE THEREOF
EP2121764B1 (en) 2007-02-28 2014-07-16 National University Corporation Kyoto Institute of Technology Viral polyhedra complexes and their use
CA2695946C (en) 2007-08-09 2017-06-13 The Board Of Regents Of The University Of Texas System Bi-layered bone-like scaffolds
CA2823954A1 (en) 2011-01-10 2012-07-19 Biomimedica, Inc. Orthopedic implants having gradient polymer alloys
JP6230691B2 (en) 2013-03-21 2017-11-15 ユープラシア ファーマシューティカルズ ユーエスエー エルエルシーＥｕｐｒａｘｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｕｓａ Ｌｌｃ Injectable sustained-release composition for treating joint inflammation and associated pain and methods of use thereof
GB201705955D0 (en) 2017-04-13 2017-05-31 Cell Guidance Systems Ltd Delivery method
GB201708233D0 (en) 2017-05-23 2017-07-05 Orthox Ltd Implantable tissue repair devices and methods for manufacturing the same

Also Published As

Publication number Publication date
EP4093425A1 (en) 2022-11-30
WO2021148779A1 (en) 2021-07-29

Similar Documents

Publication Publication Date Title
GB202111040D0 (en) Compositions and methods
EP4084784A4 (en) Compositions and methods
GB202004677D0 (en) Methods and compositions
GB202110091D0 (en) Methods and compositions
IL290325A (en) Biopharmacuetical compositions and related methods
FI4103161T3 (en) Compositions and uses thereof
SG11202108262VA (en) Bacterialcidal methods and compositions
IL304824A (en) Fospropofol methods and compositions
GB202214719D0 (en) Compositions and methods
IL310092A (en) Compositions and methods
IL309079A (en) Methods and compositions
GB202116554D0 (en) Methods and compositions
GB202113904D0 (en) Methods and compositions
GB202110572D0 (en) Compositions and methods
GB202105367D0 (en) Methods and compositions
GB202101962D0 (en) Methods and compositions
EP4103174A4 (en) Smartcore compositions and methods
GB202020623D0 (en) Methods and compositions
GB202013858D0 (en) Compositions and methods
GB202009256D0 (en) Compositions and methods
GB202002707D0 (en) Compositions and methods
GB202001526D0 (en) Methods and compositions
GB202000840D0 (en) Compositions and methods
GB202000351D0 (en) Methods and compositions
GB202316106D0 (en) Methods and compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)